SXC Health Solutions declares nominal dividend on common shares

NewsGuard 100/100 Score

SXC Health Solutions Corp. ("SXC" or the "Company") (NASDAQ: SXCI, TSX: SXC), a leading provider of pharmacy benefits management (PBM) services and Health Care Information Technology (HCIT) solutions to the healthcare benefits management industry, announced today that its board of directors has declared a nominal dividend on the issued and outstanding common shares of the Company to effect a two-for-one stock split. Shareholders of record at the close of business on September 14, 2010, will be issued one additional common share for each share owned as of that date. The additional common shares will be distributed on September 17, 2010.

"This decision by our board of directors is meant to improve access to ownership for investors by increasing the liquidity of our shares," said Mark Thierer, President and Chief Executive Officer of SXC. "The growth of our business demonstrates the consistent ability of our business model to provide flexible and customized solutions for clients to manage their healthcare costs and improve outcomes. Due to the share price performance and the long-term growth prospects of our business, we took this action to ensure that our price range is attractive to the widest possible audience of investors."

The common shares of the Company are expected to start trading on an ex-dividend basis on the TSX at market opening on September 10, 2010 and on the NASDAQ Stock Market at market opening on September 20, 2010. Between September 10, 2010 and September 20, 2010 the common shares of the Company are expected to trade with due bills on the NASDAQ Stock Market. The stock split will increase the number of common shares outstanding from approximately 30.4 million shares to approximately 60.8 million shares.

Source:

SXC HEALTH SOLUTIONS CORP.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Can generative AI truly transform healthcare into a more personalized experience?